SOPHiA GENETICS SA Operating Margin 2020-2025 | SOPH
Current and historical operating margin for SOPHiA GENETICS SA (SOPH) over the last 10 years. The current operating profit margin for SOPHiA GENETICS SA as of September 30, 2025 is -41.13%.
| SOPHiA GENETICS SA Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.07B | $-0.07B | -94.52% |
| 2025-06-30 | $0.07B | $-0.07B | -94.29% |
| 2025-03-31 | $0.07B | $-0.06B | -92.65% |
| 2024-12-31 | $0.07B | $-0.07B | -100.00% |
| 2024-09-30 | $0.07B | $-0.07B | -104.62% |
| 2024-06-30 | $0.07B | $-0.07B | -107.69% |
| 2024-03-31 | $0.06B | $-0.08B | -117.19% |
| 2023-12-31 | $0.06B | $-0.08B | -120.97% |
| 2023-09-30 | $0.06B | $-0.07B | -122.41% |
| 2023-06-30 | $0.05B | $-0.08B | -144.44% |
| 2023-03-31 | $0.05B | $-0.08B | -160.78% |
| 2022-12-31 | $0.05B | $-0.09B | -183.33% |
| 2022-09-30 | $0.05B | $-0.09B | -204.35% |
| 2022-06-30 | $0.04B | $-0.09B | -206.82% |
| 2022-03-31 | $0.04B | $-0.08B | -197.62% |
| 2021-12-31 | $0.04B | $-0.07B | -180.00% |
| 2021-09-30 | $0.04B | $-0.06B | -167.57% |
| 2021-06-30 | $0.03B | $-0.05B | -147.06% |
| 2021-03-31 | $0.03B | $-0.04B | -136.67% |
| 2020-12-31 | $0.03B | $-0.04B | -132.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.353B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |